Your browser doesn't support javascript.
loading
Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells.
Kagawa, Tetsuya; Matsumi, Yuki; Aono, Hiromichi; Ohara, Toshiaki; Tazawa, Hiroshi; Shigeyasu, Kunitoshi; Yano, Shuya; Takeda, Sho; Komatsu, Yasuhiro; Hoffman, Robert M; Fujiwara, Toshiyoshi; Kishimoto, Hiroyuki.
Afiliação
  • Kagawa T; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Matsumi Y; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Aono H; Graduate School of Science and Engineering, Ehime University, Matsuyama, Japan.
  • Ohara T; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Tazawa H; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Shigeyasu K; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Yano S; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Takeda S; Center for Graduate Medical Education, Okayama University Hospital, Okayama, Japan.
  • Komatsu Y; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Hoffman RM; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Fujiwara T; AntiCancer, Inc, San Diego, CA, USA.
  • Kishimoto H; Department of Surgery, University of California, San Diego, USA.
Cell Cycle ; 20(13): 1221-1230, 2021 07.
Article em En | MEDLINE | ID: mdl-34148497
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_energeticas / Magnetoterapia Assunto principal: Portadores de Fármacos / Receptor ErbB-2 / Magnetoterapia / Antineoplásicos Imunológicos / Nanopartículas Magnéticas de Óxido de Ferro / Hipertermia Induzida / Imunoterapia / Neoplasias Idioma: En Revista: Cell Cycle Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_energeticas / Magnetoterapia Assunto principal: Portadores de Fármacos / Receptor ErbB-2 / Magnetoterapia / Antineoplásicos Imunológicos / Nanopartículas Magnéticas de Óxido de Ferro / Hipertermia Induzida / Imunoterapia / Neoplasias Idioma: En Revista: Cell Cycle Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão